Prostate cancer and physical activity: Adaptive response to oxidative stress

Free Radical Biology and Medicine

Volumn 60, Issue , 2013, Pages 115-124

  Rebillard, Amélie ^a   Lefeuvre Orfila, Luz ^a   Gueritat, Jordan ^a   Cillard, Josiane ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Active surveillance; Free radicals; Oxidative stress; Physical activity; Prostate cancer

Indexed keywords

ANDROGEN; CASPASE 9; CYTOCHROME C; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LONG CHAIN FATTY ACID; MATRIX METALLOPROTEINASE 14; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SOMATOMEDIN; TESTOSTERONE; THIOREDOXIN 1; TRANSCRIPTION FACTOR NRF2;

AEROBIC EXERCISE; APOPTOSIS; ASIAN; CANCER INCIDENCE; CAUCASIAN; CELL DAMAGE; CELL PROLIFERATION; DNA DAMAGE; EXERCISE INTENSITY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); MITOCHONDRION; NEGRO; NONHUMAN; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; QUALITY OF LIFE; RACE DIFFERENCE; REVIEW; SECONDARY PREVENTION; SYSTEMATIC REVIEW (TOPIC);

ADAPTATION, PHYSIOLOGICAL; AGING; ANTIOXIDANTS; HUMANS; MALE; MOTOR ACTIVITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84875031994     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.02.009     Document Type: Review

References (123)

1. C. Kanso, J. Etner, B. Debré, and M. Zerbib Prostate cancer: medicoeconomic aspects Prog. Urol. 20 2010 85 90
2. K. Sennfält, G. Sandblom, P. Carlsson, and E. Varenhorst Costs and effects of prostate cancer screening in Sweden - a 15-year follow-up of a randomized trial Scand. J. Urol. Nephrol. 38 2004 291 298
3. C.L. Amling Prostate-specific antigen and detection of prostate cancer: what have we learned and what should we recommend for screening? Curr. Treat. Options Oncol. 7 2006 337 345
4. L. Khandrika, B. Kumar, S. Koul, P. Maroni, and H.K. Koul Oxidative stress in prostate cancer Cancer Lett. 282 2009 125 136
5. M. Valko, D. Leibfritz, J. Moncol, M.T.D. Cronin, M. Mazur, and J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int. J. Biochem. Cell. Biol. 39 2007 44 84
6. B. Kumar, S. Koul, L. Khandrika, R.B. Meacham, and H.K. Koul Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype Cancer Res. 68 2008 1777 1785
7. S. Reuter, S.C. Gupta, M.M. Chaturvedi, and B.B. Aggarwal Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med 49 2010 1603 1616
8. Q. Ma Transcriptional responses to oxidative stress: pathological and toxicological implications Pharmacol. Ther. 125 2010 376 393
9. P.M. Clarkson, and H.S. Thompson Antioxidants: what role do they play in physical activity and health? Am. J. Clin. Nutr 72 2000 637 646
10. Z. Radak, H.Y. Chung, E. Koltai, and S. Goto Exercise, oxidative stress and hormesis Ageing Res. Rev. 7 2007 34 42
11. L.L. Ji, Z. Radàk, and S. Goto Hormesis and exercise: how the cell copes with oxidative stress. Am. J Pharmacol. Toxicol. 3 2008 44 58
12. M.C. Gomez-Cabrera, E. Domenech, and J. Viña Moderate exercise is an antioxidant: upregulation of antioxidant genes by training Free Radic. Biol. Med. 44 2008 126 131
13. S. Kenfield, M. Stampfer, E. Giovannucci, and J.M. Chan Physical activity and survival after prostate cancer diagnosis in the Health Professionals Follow-Up Study J. Clin. Oncol. 29 2011 726 732
14. M.E. Parent, M.C. Rousseau, M. El-Zein, B. Latreille, M. Désy, and J. Siemiatycki Occupational and recreational physical activity during adult life and the risk of cancer among men Cancer Epidemiol 35 2011 151 159
15. J.A. Antonelli, L.W. Jones, L.L. Bañez, J.A. Thomas, K. Anderson, L.A. Taylor, L. Gerber, T. Anderson, C. Hoyo, D. Grant, and S.J. Freedland Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy J. Urol. 182 2009 2226 2231
16. E.L. Giovannucci, Y. Liu, M.F. Leitzmann, M.J. Stampfer, and W.C. Willett A prospective study of physical activity and incident and fatal prostate cancer Arch. Intern. Med. 165 2005 1005 1010
17. G. Clarke, and A.S. Whittemore Prostate cancer risk in relation to anthropometry and physical activity: the National Health and Nutrition Examination Survey I Epidemiological Follow-Up Study Cancer Epidemiol. Biomarkers Prev 9 2000 875 881
18. A.J. Littman, A.R. Kristal, and E. White Recreational physical activity and prostate cancer risk (United States) Cancer Causes Control 17 2006 831 841
19. A.V. Patel, C. Rodriguez, E.J. Jacobs, L. Solomon, M.J. Thun, and E.E. Calle Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men Cancer Epidemiol. Biomarkers Prev 14 2005 275 279
20. S.G. Wannamethee, A.G. Shaper, and M. Walker Physical activity and risk of cancer in middle-aged men Br. J. Cancer 85 2001 1311 1316
21. A. Krishnadasan, N. Kennedy, Y. Zhao, H. Morgenstern, and B. Ritz Nested case-control study of occupational physical activity and prostate cancer among workers using a job exposure matrix Cancer Causes Control 19 2008 107 114
22. A. Norman, T. Moradi, G. Gridley, M. Dosemeci, B. Rydh, O. Nyrén, and A. Wolk Occupational physical activity and risk for prostate cancer in a nationwide cohort study in Sweden Br. J. Cancer 86 2002 70 75
23. N.F. Johnsen, A. Tjønneland, B.L. Thomsen, J. Christensen, S. Loft, C. Friedenreich, T.J. Key, N.E. Allen, P.H. Lahmann, L. Mejlvig, K. Overvad, R. Kaaks, S. Rohrmann, H. Boing, G. Misirli, A. Trichopoulou, D. Zylis, R. Tumino, V. Pala, H.B. Bueno-de-Mesquita, L.A. Kiemeney, L.R. Suárez, C.A. Gonzalez, M.J. Sánchez, J.M. Huerta, A.B. Gurrea, J. Manjer, E. Wirfält, K.T. Khaw, N. Wareham, P. Boffetta, L. Egevad, S. Rinaldi, and E. Riboli Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort Int. J. Cancer 125 2009 902 908
24. I. Thune, and A.S. Furberg Physical activity and cancer risk: dose-response and cancer, all sites and site-specific Med. Sci. Sports Exerc. 33 2001 530 550
25. I. Thune, and E. Lund Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men Cancer Causes Control 5 1994 549 556
26. E. Giovannucci, M. Leitzmann, D. Spiegelman, E.B. Rimm, G.A. Colditz, M.J. Stampfer, and W.C. Willett A prospective study of physical activity and prostate cancer in male health professionals Cancer Res. 58 1998 5117 5122
27. S. Liu, I.M. Lee, P. Linson, U. Ajani, J.E. Buring, and C.H. Hennekens A prospective study of physical activity and risk of prostate cancer in US physicians Int. J. Epidemiol. 29 2000 29 35
28. N. Orsini, R. Bellocco, M. Bottai, M. Pagano, S.O. Andersson, J.E. Johansson, E. Giovannucci, and A. Wolk A prospective study of lifetime physical activity and prostate cancer incidence and mortality Br. J. Cancer 101 2009 1932 1938
29. O. Cussenot, and A. Valeri Heterogeneity in genetic susceptibility to prostate cancer Eur. J. Intern. Med. 12 2001 11 16
30. P. Berthon, A. Valeri, A. Cohen-Akenine, E. Drelon, T. Paiss, G. Wöhr, A. Latil, P. Millasseau, I. Mellah, N. Cohen, H. Blanché, C. Bellané-Chantelot, F. Demenais, P. Teillac, A. Le Duc, R. de Petriconi, R. Hautmann, I. Chumakov, L. Bachner, N.J. Maitland, R. Lidereau, W. Vogel, G. Fournier, P. Mangin, and O. Cussenot Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43 Am. J. Hum. Genet. 62 1998 1416 1424
31. G. Cancel-Tassin, A. Latil, A. Valéri, P. Mangin, G. Fournier, P. Berthon, and O. Cussenot PCAP is the major known prostate cancer predisposing locus in families from south and west Europe Eur. J. Hum. Genet. 9 2001 135 142
32. M.K. Karayi, D.E. Neal, and A.F. Markham Current status of linkage studies in hereditary prostate cancer BJU Int 86 2000 659 669
33. M.S. Hovenanian, and C.L. Deming The heterologous growth of cancer of the human prostate Surg. Gynecol. Obstet. 86 1948 29 35
34. E.L. Wynder, K. Laakso, M. Sotarauta, and D.P. Rose Metabolic epidemiology of prostatic cancer Prostate 5 1984 47 53
35. A. McTiernan Mechanisms linking physical activity with cancer Nat. Rev. Cancer 8 2008 205 211
36. A.S. Whittemore, L.N. Kolonel, A.H. Wu, E.M. John, R.P. Gallagher, G.R. Howe, J.D. Burch, J. Hankin, D.M. Dreon, D.W. West, T. Chong-Ze, and R. Paffenbarger Jr. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada J. Natl. Cancer Inst. 87 1995 652 661
37. O.W. Brawley, and K.T.I. Knopf The epidemiology of prostate cancer. Part II.: The risk factors. Semin Urol. Oncol. 16 1998 193 201
38. Y. Liu, F. Hu, D. Li, F. Wang, L. Zhu, W. Chen, J. Ge, R. An, and Y. Zhao Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis Eur. Urol. 60 2011 1029 1044
39. I.M. Lee, H.D. Sesso, J.J. Chen, and R.S. Paffenbarger Jr. Does physical activity play a role in the prevention of prostate cancer? Epidemiol. Rev. 23 2001 132 137
40. C.M. Friedenreich, and I. Thune A review of physical activity and prostate cancer risk Cancer Causes Control 12 2001 461 475
41. S. Young-McCaughan Potential for prostate cancer prevention through physical activity World J. Urol 30 2012 167 169
42. U. Monga, S.L. Garber, J. Thornby, C. Vallbona, A.J. Kerrigan, T.N. Monga, and K.P. Zimmermann Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy Arch. Phys. Med. Rehabil. 88 2007 1416 1422
43. D. Ornish, G. Weidner, W.R. Fair, R. Marlin, E.B. Pettengill, C.J. Raisin, S. Dunn-Emke, L. Crutchfield, F.N. Jacobs, R.J. Barnard, W.J. Aronson, P. McCormac, D.J. McKnight, J.D. Fein, A.M. Dnistrian, J. Weinstein, T.H. Ngo, N.R. Mendell, and P.R. Carroll Intensive lifestyle changes may affect the progression of prostate cancer J. Urol. 174 2005 1065 1070
44. K.A. Esser, C.E. Harpole, G.S. Prins, and A.M. Diamond Physical activity reduces prostate carcinogenesis in a transgenic model Prostate 69 2009 1372 1377
45. X. Zheng, X.X. Cui, M.T. Huang, Y. Liu, W.J. Shih, Y. Lin, Y.P. Lu, G.C. Wagner, and A.H. Conney Inhibitory effect of voluntary running wheel exercise on the growth of human pancreatic Panc-1 and prostate PC-3 xenograft tumors in immunodeficient mice Oncol. Rep. 19 2008 1583 1588
46. X. Zheng, X.X. Cui, Z. Gao, Y. Zhao, Y. Shi, M.T. Huang, Y. Liu, G.C. Wagner, Y. Lin, W.J. Shih, C.V. Rao, C.S. Yang, and A.H. Conney Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors to androgen independence Exp. Ther. Med 2 2011 221 228
47. C.N. Tymchuk, R.J. Barnard, D. Heber, and W.J. Aranson Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth J. Urol. 16 2001 1185 1189
48. P.S. Leung, W.J. Aronson, T.H. Ngo, L.A. Golding, and R.J. Barnard Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro J. Appl. Physiol. 96 2004 450 454
49. R.J. Barnard, T.H. Ngo, P.S. Leung, W.J. Aronson, and L.A. Golding A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro Prostate 56 2003 201 206
50. Soliman, S.; Aronson, W.J.; Barnard, R.J. Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention. Evid. Based Complement. Alternat. Med.20115290532011.
51. R.J. Barnard, P.S. Leung, W.J. Aronson, P. Cohen, and L.A. Golding A mechanism to explain how regular exercise might reduce the risk for clinical prostate cancer Eur. J. Cancer Prev. 16 2007 415 421
52. W.J. Aronson, R.J. Barnard, S.J. Freedland, S. Henning, D. Elashoff, P.M. Jardack, P. Cohen, D. Heber, and N. Kobayas Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer J. Urol. 183 2010 345 350
53. H. Sies, and E. Cadenas Oxidative stress: damage to intact cells and organs Philos. Trans. R. Soc. London B Biol. Sci 311 1985 617 631
54. D. Harman Aging: a theory based on free radical and radiation chemistry J. Gerontol. 11 1956 298 300
55. J. Luo, N.L. Solimini, and S.J. Elledge Principles of cancer therapy: oncogene and non-oncogene addiction Cell 136 2009 823 837
56. S. Veeramani, T.-C. Yuan, F.-F. Lin, and M.-F. Lin Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells Oncogene 27 2008 5057 5068
57. S. Veeramani, Y.W. Chou, F.C. Lin, S. Muniyan, F.F. Lin, S. Kumar, Y. Xie, S.M. Lele, Y. Tu, and M.F. Lin Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells Free Radic. Biol. Med. 53 2012 95 108
58. Y.H. Lin, C.L. Chen, C.P. Hou, P.L. Chang, and K.H. Tsui A comparison of androgen deprivation therapy versus surgical castration for patients with advanced prostatic carcinoma Acta Pharmacol. Sin. 32 2011 537 542
59. M. Shiota, A. Yokomizo, and S. Naito Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer Free Radic. Biol. Med 51 2011 1320 1328
60. M.J. Linja, K.J. Savinainen, T.L. Tammela, J.J. Isola, and T. Visakorpi Expression of ERalpha and ERbeta in prostate cancer Prostate 55 2003 180 186
61. A.M. Miró, J. Sastre-Serra, D.G. Pons, A. Valle, P. Roca, and J. Oliver 17β-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio J. Steroid Biochem. Mol. Biol. 123 2011 133 139
62. W.A. Ricke, S.J. McPherson, J.J. Bianco, G.R. Cunha, Y. Wang, and G.P. Risbridger Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling FASEB J. 22 2008 1512 1520
63. M.T. Harris, R.S. Feldberg, K.M. Lau, N.H. Lazarus, and D.E. Cochrane Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate Prostate 44 2000 19 25
64. E. Ho, T.W. Boileaun, and T.M. Bray Dietary influences on endocrine-inflammatory interactions in prostate cancer development Arch. Biochem. Biophys. 428 2004 109 117
65. N. Khansari, Y. Shakiba, and M. Mahmoudi Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer Recent Pat. Inflammation Allergy Drug Discovery 3 2009 73 80
66. N. Azad, Y. Rojanasakul, and V. Vallyathan Inflammation and lung cancer: roles of reactive oxygen/nitrogen species J. Toxicol. Environ. Health B Crit. Rev. 11 2008 1 15
67. S.S. Brar, Z. Corbin, T.P. Kennedy, R. Hemendinger, L. Thornton, B. Bommarius, R.S. Arnold, A.R. Whorton, A.B. Sturrock, T.P. Huecksteadt, M.T. Quinn, K. Krenitsky, K.G. Ardie, J.D. Lambeth, and J.R. Hoidal NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells Am. J. Physiol. Cell Physiol. 285 2003 353 369
68. N.N. Tam, Y. Gao, Y.K. Leung, and S.M. Ho Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth Am. J. Pathol 163 2003 2513 2522
69. H.L. Nguyen, S. Zucker, K. Zarrabi, P. Kadam, C. Schmidt, and J. Cao Oxidative stress and prostate cancer progression are elicited by membrane-type 1 matrix metalloproteinase Mol. Cancer Res. 9 2011 1305 1318
70. F. Mehraein-Ghomi, H.S. Basu, D.R. Church, F.M. Hoffmann, and G. Wilding Androgen receptor requires JunD as a coactivator to switch on an oxidative stress generation pathway in prostate cancer cells Cancer Res. 70 2010 4560 4568
71. A. Goodwin, S. Jadallah, A. Toubaji, K. Lecksell, J. Hicks, J. Kowalski, G. Bova, A. De Marzo, G. Netto, and R.A. Casero Jr. Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues Prostate 68 2008 766 772
72. A. Smith, Y. Karpova, R. D'Agostino, M. Willingham, and G. Kulik Expression of the Bcl-2 protein BAD promotes prostate cancer growth PLoS One 4 2009 1 6
73. J.E. Klaunig, Y. Xu, J.S. Isenberg, S. Bachowski, K.L. Kolaja, J. Jiang, D.E. Stevenson, and E.F. Walborg Jr. The role of oxidative stress in chemical carcinogenesis Environ. Health Perspect. 106 1998 289 295
74. WAF1/CIP1-mediated G2/M arrest in a p53-deficient human lung cancer cell Biochem. Biophys. Res. Commun. 293 2002 1248 1253
75. G. Waris, and H. Ahsan Reactive oxygen species: role in the development of cancer and various chronic conditions J. Carcinog 5 2006 14 22
76. M. Valko, C.J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur Free radicals, metals and antioxidants in oxidative stress-induced cancer Chem. Biol. Interact. 160 2006 1 40
77. I. Vivanco, N. Palaskas, C. Tran, S.P. Finn, G. Getz, N.J. Kennedy, J. Jiao, J. Rose, W. Xie, M. Loda, T. Golub, I.K. Mellinghoff, R.J. Davis, H. Wu, and C.L. Sawyers Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN Cancer Cell 11 2007 555 569
78. X. Ouyang, W.J. Jessen, H. Al-Ahmadie, A.M. Serio, Y. Lin, W.J. Shih, V.E. Reuter, P.T. Scardino, M.M. Shen, B.J. Aronow, A.J. Vickers, W.L. Gerald, and C. Abate-Shen Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer Cancer Res. 68 2008 2132 2144
79. D.A. Frohlich, M.T. McCabe, R.S. Arnold, and M.L. Day The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis Oncogene 27 2008 4353 4362
80. J. Pincemail, M. Meurisse, R. Limet, and J.O. Defraigne Espèces oxygénées activées, antioxidants et cancer Vaisseaux, Coeur, Poumons 4 4 1999
81. W. Shan, W. Zhong, R. Zhao, and T.D. Oberley Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression Free Radic. Biol. Med. 49 2010 2078 2087
82. A.V. Budanov Stress-responsive sestrins link p53 with redox regulation and mammalian target of rapamycin signaling Antioxid. Redox Signaling 15 2011 1679 1690
83. A.A. Sablina, A.V. Budanov, G.V. Ilyinskaya, L.S. Agapova, J.E. Kravchenko, and P.M. Chumakov The antioxidant function of the p53 tumor suppressor Nat. Med 11 2005 1306 1313
84. T. Visakorpi, O.P. Kallioniemi, A. Heikkinen, T. Koivula, and J. Isola Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation J. Natl. Cancer Inst. 84 1992 883 887
85. N.M. Navone, P. Troncoso, L.L. Pisters, T.L. Goodrow, J.L. Palmer, W.W. Nichols, A.C. von Eschenbach, and C.J. Conti p53 protein accumulation and gene mutation in the progression of human prostate carcinoma J. Natl. Cancer Inst. 85 1993 1657 1669
86. S.G. Chi, W. Ralph, W. deVere, F.J. Meyers, D.B. Siders, F. Lee, and P.H. Gumerlock p53 in prostate cancer: frequent expressed transition mutations J. Natl. Cancer Inst. 86 1994 926 933
87. D.J. Grignon, R. Caplan, F.H. Sarkar, C.A. Lawton, E.H. Hammond, M.V. Pilepich, J.D. Forman, J. Mesic, K.K. Fu, R.A. Abrams, T.F. Pajak, W.U. Shipley, and J.D. Cox p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610 J. Natl. Cancer Inst. 89 1997 158 165
88. S. North, M. Moenner, and A. Bikfalvi Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors Cancer Lett 218 2005 1 14
89. N.M. Mazure, E.Y. Chen, P. Yeh, K.R. Laderoute, and A.J. Giaccia Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression Cancer Res. 56 1996 3436 3440
90. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat. Rev. Cancer 3 2003 401 410
91. M. Ferrando, G. Gueron, B. Elguero, J. Giudice, A. Salles, F.C. Leskow, E.A. Jares-Erijman, L. Colombo, R. Meiss, N. Navone, A. De Siervi, and E. Vazquez Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer Angiogenesis 14 2011 467 479
92. D. Dreher, and A.F. Junod Role of oxygen free radicals in cancer development Eur. J. Cancer 1 1996 30 38
93. C.C. Yeh, C. Lee, and R. Dahiya DNA mismatch repair enzyme activity and gene expression in prostate cancer Biochem. Biophys. Res. Commun. 285 2001 409 413
94. Y. Chen, J. Wang, M.M. Fraig, J. Metcalf, W.R. Turner, N.K. Bissada, D.K. Watson, and C.W. Schweinfest Defects of DNA mismatch repair in human prostate cancer Cancer Res. 61 2001 4112 4121
95. Donkena, K.V.; Young, C.Y.; Tindall, D.J. Oxidative stress and DNA methylation in prostate cancer. Obstet. Gynecol. Int.20103020512010.
96. T.D. Oberley, W. Zhong, L.I. Szweda, and L.W. Oberley Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium Prostate 44 2000 144 155
97. G.D. Dakubo, R.L. Parr, L.C. Costello, R.B. Franklin, and R.E. Thayer Altered metabolism and mitochondrial genome in prostate cancer J. Clin. Pathol. 59 2006 10 16
98. A. Almushatat, D. Talwar, P.A. McArdle, C. Williamson, N. Sattar, D.S. O'Reilly, M.A. Underwood, and D.C. McMillan Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer Int. J. Cancer 118 2006 1051 1053
99. Z. Custovic, K. Zarkovic, M. Cindric, A. Cipak, I. Jurkovic, Z. Sonicki, K. Uchida, and N. Zarkovic Lipid peroxidation product acrolein as a predictive biomarker of prostate carcinoma relapse after radical surgery Free Radic. Res. 44 2010 497 504
100. O. Yossepowitch, I. Pinchuk, U. Gur, A. Neumann, D. Lichtenberg, and J. Baniel Advanced but not localized prostate cancer is associated with increased oxidative stress J. Urol. 178 2007 1238 1244
101. D.A. Barocas, S. Motley, M.S. Cookson, S.S. Chang, D.F. Penson, Q. Dai, G. Milne, L.J. Roberts 2nd, J. Morrow, R.S. Concepcion, J.A. Smith Jr., and J.H. Fowke Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer J. Urol. 185 2011 2102 2107
102. K.J. Davies, A.T. Quintanilha, G.A. Brooks, and L. Packer Free radicals and tissue damage produced by exercise Biochem. Biophys. Res. Commun. 107 1982 1198 1205
103. H.M. Alessio, A.H. Goldfarb, and R.G. Cutler MDA content increases in fast- and slow twitch skeletal muscle with intensity of exercise in a rat Am. J. Physiol. 255 1988 874 877
104. C. Leeuwenburgh, and J.W. Heinecke Oxidative stress and antioxidants in exercise Curr. Med. Chem. 8 2001 829 838
105. M.C. Fogarty, C.M. Hughes, G. Burke, J.C. Brown, T.R. Trinick, E. Duly, D.M. Bailey, and G.W. Davison Exercise-induced lipid peroxidation: implications for deoxyribonucleic acid damage and systemic free radical generation Environ. Mol. Mutagen. 52 2011 35 42
106. S.K. Powers, and M.J. Jackson Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production Physiol. Rev. 88 2008 1243 1276
107. H. Ogonovszky, M. Sasvári, A. Dosek, I. Berkes, T. Kaneko, S. Tahara, H. Nakamoto, S. Goto, and Z. Radak The effects of moderate, strenuous, and overtraining on oxidative stress markers and DNA repair in rat liver Can. J. Appl. Physiol. 30 2005 186 195
108. S. Goto, and Z. Radak Hormetic effects of reactive oxygen species by exercise: a view from animal studies for successful aging in human Dose Response 8 2010 68 72
109. C. Groussard, F. Rannou-Bekeno, G. Machefer, M. Chevanne, S. Vincent, O. Sergent, J. Cillard, and A. Gratas-Delamarche Changes in blood lipid peroxidation markers and antioxidants after a single sprint anaerobic exercise Eur. J. Appl. Physiol. 89 2003 14 20
110. M.G. Nikolaidis, A. Kyparos, C. Spanou, V. Paschalis, A.A. Theodorou, and I.S. Vrabas Redox biology of exercise: an integrative and comparative consideration of some overlooked issues J. Exp. Biol. 215 2012 1615 1625
111. T. Ashton, I.S. Young, J.R. Peters, E. Jones, S.K. Jackson, B. Davies, and C.C. Rowlands Electron spin resonance spectroscopy, exercise, and oxidative stress: an ascorbic acid intervention study J. Appl. Physiol. 87 1999 2032 2036
112. 2 release by mitochondria from rat skeletal muscle Arch. Biochem. Biophys. 372 1999 315 320
113. S.K. Powers, D. Criswell, J. Lawler, D. Martin, F.K. Lieu, L.L. Ji, and R.A. Herb Rigorous exercise training increases superoxide dismutase activity in ventricular myocardium Am. J. Physiol. 265 1993 2094 2098
114. H. Miyazaki, S. Oh-ishi, T. Ookawara, T. Kizaki, K. Toshinai, S. Ha, S. Haga, L.L. Ji, and H. Ohno Strenuous endurance training in humans reduces oxidative stress following exhausting exercise Eur. J. Appl. Physiol. 84 2001 1 6
115. J. Finaud, G. Lac, and E. Filaire Oxidative stress: relationship with exercise and training Sports Med 36 2006 327 358
116. S. Goto, and Z. Radak Regular exercise attenuates oxidative stress in aging rat tissues: a possible mechanism toward anti-aging medicine J. Exerc. Sci. Fit. 5 2007 1 6
117. P.T. Campbell, M.D. Gross, J.D. Potter, K.H. Schmitz, C. Duggan, A. Mc Tiernan, and C.M. Ulrich Effect of exercise on oxidative stress: a 12-month randomized, controlled trial Med. Sci. Sports. Exerc. 42 2010 1448 1453
118. L.L. Ji, C. Leeuwenburgh, S. Leichtweis, M. Gore, R. Fiebig, J. Hollander, and J. Bejma Oxidative stress and aging: role of exercise and its influences on antioxidant systems Ann. N. Y. Acad. Sci 854 1998 102 117
119. F.N. Daussin, L. Rasseneur, J. Bouitbir, A.L. Charles, S.P. Dufour, B. Geny, Y. Burelle, and R. Richard Different timing of changes in mitochondrial functions following endurance training Med. Sci. Sports Exerc. 44 2012 217 224
120. H. Feng, C. Kang, J. Dickman, R. Koenig, I. Awoyinka, Y. Zhang, and L.L. Ji Training-induced mitochondrial adaptation: role of PGC-1α, NFκB and β-blockade Exp. Physiol. 2012 2012 069286
121. L.L. Ji, M.C. Gomez-Cabrera, and J. Viña Activation of cellular antioxidant signaling pathway Ann. N.Y. Acad. Sci 1067 2006 425 435
122. P. Hojman, C. Dethlefsen, C. Brandt, J. Hansen, L. Pedersen, and B.K. Pedersen Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth Am. J. Physiol. Endocrinol. Metab. 301 2011 504 510
123. A.M. Petersen, and B.K. Pedersen The anti-inflammatory effect of exercise J. Appl. Physiol. 98 2005 1154 1162